Unlocking the Power of Proteins
Chemistry of Life Processes Institute (CLP) at Northwestern University is pioneering the greatest wave of biomedical innovation since the Human Genome Project opened the door for individualized medicine two decades ago. Known as proteomics, this fast-growing field identifies and measures the various forms of proteins (proteoforms) that link genes and disease in order to diagnose and treat threats to human health.
CLP houses the premier center for proteomics under the leadership of Neil Kelleher, a leading advocate for the Human Proteoform Project, a global initiative to map all proteins in the human body. Leveraging an unsurpassed capability to analyze proteins, the Institute is ready to launch the next era of precision medicine by discovering the changes in proteoforms that cause disease, creating sensitive diagnostics to catch disease early and prevent organ damage, and identifying new, proteoform-enabled targets for drug development and delivery.
Through its Convergence Research Initiatives, CLP assembles world-class teams of Northwestern chemists, clinicians, life scientists and engineers to transform how we diagnose, treat and, someday, cure devasting diseases that have eluded effective treatments, including liver and pancreatic cancers, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Training the Next Generation of Scientists
CLP’s world-class research and training programs prepare Northwestern undergraduates and graduate students to tackle tomorrow’s biggest biomedical challenges. Students and trainees are required to work with two mentors from different disciplines to learn multiple languages of scientific inquiry. Our curricula emphasize skills development, rigor, reproducibility and hands-on training across a broad spectrum of instruments and methods.
Together with our partners across the University, Northwestern Medicine, and Lurie Cancer Center, we pioneer new science and hasten the delivery of life-changing innovations to society.
“At CLP, mapping the universe of human proteins is already underway, and with donor support, we’ll be able to accelerate the ability to detect human disease earlier and develop precision medicines. We’re powering drug development with truly next generation proteomics.”
Neil L. Kelleher, PhD | Director of CLP
BY THE NUMBERS
INVESTING IN INNOVATION
$1.2M Invested in CLP Institute seed projects
$24M New external funding resulting from seed grants
IN THE PIPELINE
35 New drug candidates
31 Medical devices
9 Diagnostic technologies
BENCH TO SOCIETY
33 New companies spun out by Institute faculty
$2.5B External investments in new companies
Read All News
Translating Proteomics Episode 9 – Are Proteins a Myth? With Special Guest Neil Kelleher
In Nautilus Biotechnology's Translating Proteomics episode titled “Harnessing Proteoforms to Understand Life’s Complexity“, Parag Mallick and Andreas Huhmer discussed why proteoforms are important in a theoretical sense. In this episode, Parag sits down with...
CLP’s Prestigious NIH Predoctoral Training Program Welcomes New Trainees
Educating the next generation of transdisciplinary scientists is an important priority for the Chemistry of Life Processes Institute. This year’s newest NIH Predoctoral Training Program participants Mauricio Ceballos, Noah Marx, Robert Reichert, Grace Watkins, and Mia...
2024 Lambert Fellows Dive Deep into Biomedical Research
Northwestern Chemistry majors, Ethan Brazelton, Julian Novin and Tristan Weng were named this year’s recipients of the Chemistry of Life Processes Institute’s most prestigious undergraduate award, the Lambert Fellowship. The program provides mentorship and a generous...
CLP Trainees and Researchers Uncover Hijackable E3 Ligase for Targeted Protein degradation
In a recent study published in Nature Chemical Biology, Chemistry of Life Processes Institute (CLP) member Xiaoyu Zhang and three CLP Predoctoral Program trainees, Ananya A. Basu, Assa Magassa, and Miguel A. Campos, made an important discovery that sheds light on the...
Recent and Upcoming Events
Research Forum
Where: Silverman #3-510 When: Monday, Oct. 7, 2024, 4:00-5:30 pm Who: Miguel Campos Discovery of Novel DCAF16 Ligands for Targeted Protein Degradation and Alondra Sanchez Discovery of Degradation Pathways by Functional Genomics
Discovery and New Chemistry at the Bacterial Cell Surface
Who: Lynette Cegelski, PhD Professor of Chemistry Stanford University Where: Pancoe Auditorium When: Monday, Oct. 21, 2024, 4:00 pm Professor Cegelski will discuss her lab’s unanticipated discoveries at the cell surface and their identification of urgently needed...